Treatment of vascular dementia: Evidence from trials with non-cholinergic drugs

Journal of the Neurological Sciences

Volumn 226, Issue 1-2 SPEC.ISS., 2004, Pages 67-70

  Pantoni, Leonardo ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Randomized clinical trials; Subcortical vascular dementia; Therapy; Vascular dementia

Indexed keywords

ACETYLSALICYLIC ACID; BUFLOMEDIL; CEREBROLYSIN; CITICOLINE; CYCLANDELATE; DENBUFYLLINE; DIHYDROERGOTOXINE MESILATE; GINKGO BILOBA EXTRACT; MEMANTINE; NAFTIDROFURYL; NICARDIPINE; NICERGOLINE; NIMODIPINE; OXIRACETAM; PENTOXIFYLLINE; PIRACETAM; PLACEBO; POSATIRELIN; PROPENTOFYLLINE; PYRITINOL; SULODEXIDE; TRIFLUSAL; VINCAMINE; VINPOCETINE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SAMPLE SIZE;

DEMENTIA, VASCULAR; ERGOT ALKALOIDS; HUMANS; NOOTROPIC AGENTS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; VASODILATOR AGENTS;

EID: 8644260834     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.09.014     Document Type: Conference Paper

References (21)

1. R.S. Doody, J.C. Stevens, C. Beck, R.M. Dubinsky, J.A. Kaye, and L. Gwyther Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 2001 1154 1166
2. J.S. Meyer, R.L. Rogers, K. McClintic, K.F. Mortel, and J. Lotfi Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study J. Am. Geriatr. Soc. 37 1989 549 555
3. European Pentoxifylline Multi-Infarct Dementia Study Group European pentoxifylline multi-infarct dementia study Eur. Neurol. 36 1996 315 321
4. L. Parnetti, L. Ambrosoli, G. Agliati, P. Caratozzolo, L. Fossati, and L. Frattola Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs. placebo Acta Neurol. Scand. 93 1996 456 463
5. J. Marcusson, M. Rother, B. Kittner, M. Rossner, R.J. Smith, and T. Babic A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group Dement. Geriatr. Cogn. Disord. 8 1997 320 328
6. W.M. Herrmann, K. Stephan, K. Gaede, and M. Apeceche A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia Dement. Geriatr. Cogn. Disord. 8 1997 9 17
7. L. Pantoni, C. Bianchi, M. Beneke, D. Inzitari, A. Wallin, and T. Erkinjuntti The scandinavian multi-infarct dementia trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia J. Neurol. Sci. 175 2000 116 123
8. G. Wilcock, H.J. Mobius, A. Stoffler for the MMM 500 group A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) Int. Clin. Psychopharmacol. 17 2002 297 305
9. J.M. Orgogozo, A.S. Rigaud, A. Stoffler, H.J. Mobius, and F. Forette Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300) Stroke 33 2002 1834 1839
10. T. Erkinjuntti, A. Kurz, S. Gauthier, R. Bullock, S. Lilienfeld, and C.V. Damaraju Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial Lancet 359 2002 1283 1290
11. S. Black, G.C.. Roman, D.S. Geldmacher, S. Salloway, J. Hecker, A. Burns for the donepezil 307 vascular dementia study group Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial Stroke 34 2003 2323 2330
12. D. Wilkinson, R. Doody, R. Helme, K. Taubman, J. Mintzer, and A. Kertesz Donepezil in vascular dementia: a randomized, placebo-controlled study Neurology 61 2003 479 486
13. A. Wallin, V. Milos, M. Sjögren, L. Pantoni, and T. Erkinjuntti Classification and subtypes of vascular dementia T. Erkinjuntti S. Gauthier Vascular cognitive impairment 2002 Martin Dunitz London 27 42
14. L. Pantoni Subtypes of vascular dementia and their pathogenesis: a critical overview J. Bowler V. Hachinski Vascular cognitive impairment: preventable dementia 2003 Oxford University Press Oxford 217 229
15. G.C. Román, T. Erkinjuntti, A. Wallin, L. Pantoni, and H.C. Chui Subcortical ischaemic vascular dementia Lancet Neurol. 1 2002 426 436
16. D. Inzitari, T. Erkinjuntti, A. Wallin, T. del Ser, M. Romanelli, and L. Pantoni Subcortical vascular dementia as a specific target for clinical trials Ann. N. Y. Acad. Sci. 903 2000 510 521
17. T. Erkinjuntti, D. Inzitari, L. Pantoni, A. Wallin, P. Scheltens, and K. Rockwood Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials: is subcortical vascular dementia a solution? Ann. N. Y. Acad. Sci. 903 2000 262 272
18. T. Erkinjuntti, D. Inzitari, L. Pantoni, A. Wallin, P. Scheltens, and K. Rockwood Research criteria for subcortical vascular dementia in clinical trials J. Neural Transm., Suppl. 59 2000 23 30
19. L. Pantoni, R. Rossi, D. Inzitari, C. Bianchi, M. Beneke, and T. Erkinjuntti Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the scandinavian multi-infarct dementia trial J. Neurol. Sci. 175 2000 124 134
20. H.C. Chui, W. Mack, J.E. Jackson, D. Mungas, B.R. Reed, and J. Tinklenberg Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability Arch. Neurol. 57 2000 191 196
21. T. Pohjasvaara, R. Mantyla, R. Ylikoski, M. Kaste, and T. Erkinjuntti Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia Stroke 31 2000 2952 2957